|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heare T, Hensley MA and Dell'Orfano S:
Bone tumors: Osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr.
21:365–372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harrison DJ, Geller DS, Gill JD, Lewis VO
and Gorlick R: Current and future therapeutic approaches for
osteosarcoma. Expert Rev Anticancer Ther. 18:39–50. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Strobel O, Neoptolemos J, Jäger D and
Büchler MW: Optimizing the outcomes of osteosarcoma surgery. Nat
Rev Clin Oncol. 16:11–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen LL and Carmichael GG: Long noncoding
RNAs in mammalian cells: What, where, and why? Wiley Interdiscip
Rev RNA. 1:2–21. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rafiee A, Riazi-Rad F, Havaskary M and
Nuri F: Long noncoding RNAs: Regulation, function and cancer.
Biotechnol Genet Eng Rev. 34:153–180. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mei D, Song H, Wang K, Lou Y, Sun W, Liu
Z, Ding X and Guo J: Up-regulation of SUMO1 pseudogene 3 (SUMO1P3)
in gastric cancer and its clinical association. Med Oncol.
30:7092013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lian Y, Xiong F, Yang L, Bo H, Gong Z,
Wang Y, Wei F, Tang Y, Li X, Liao Q, et al: Long noncoding RNA
AFAP1-AS1 acts AS a competing endogenous RNA of miR-423-5p to
facilitate nasopharyngeal carcinoma metastasis through regulating
the Rho/Rac pathway. J Exp Clin Cancer Res. 37:2532018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu LJ, Yu XJ, Wei B, Hui HX, Sun Y, Dai J
and Chen XF: Long non-coding RNA DUXAP8 regulates proliferation and
invasion of esophageal squamous cell cancer. Eur Rev Med Pharmacol
Sci. 22:2646–2652. 2018.PubMed/NCBI
|
|
13
|
Ma HW, Xie M, Sun M, Chen TY, Jin RR, Ma
TS, Chen QN, Zhang EB, He XZ, De W and Zhang ZH: The pseudogene
derived long noncoding RNA DUXAP8 promotes gastric cancer cell
proliferation and migration via epigenetically silencing PLEKHO1
expression. Oncotarget. 8:52211–52224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang H, Shi X, Ye G, Xu Y, Xu J, Lu J and
Lu W: Up-regulated long non-coding RNA DUXAP8 promotes cell growth
through repressing Krüppel-like factor 2 expression in human
hepatocellular carcinoma. Onco Targets Ther. 11:7429–7436. 2019.
View Article : Google Scholar
|
|
15
|
AmbRoS V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cummins JM, He Y, Leary RJ, Pagliarini R,
Diaz LA Jr, Sjoblom T, Barad O, Bentwich Z, Szafranska AE,
Labourier E, et al: The colorectal microRNAome. Proc Natl Acad Sci
USA. 103:3687–3692. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weber CE, Luo C, Hotz-Wagenblatt A,
Gardyan A, Kordass T, Holland-Letz T, Osen W and Eichmüller SB:
miR-339-3p is a tumor suppressor in melanoma. Cancer Res.
76:3562–3571. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jain M, Zhang L, He M, Zhang YQ, Shen M
and Kebebew E: TOP2A is overexpressed and is a therapeutic target
for adrenocortical carcinoma. Endocr Relat Cancer. 20:361–370.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ejlertsen B, Jensen MB, Nielsen KV,
Balslev E, Rasmussen BB, Willemoe GL, Hertel PB, Knoop AS,
Mouridsen HT and Brünner N: HER2, TOP2A, and TIMP-1 and
responsiveness to adjuvant anthracycline-containing chemotherapy in
high-risk breast cancer patients. J Clin Oncol. 28:984–990. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang S, Jiang H, Xu Z, Jiang Y, She Y,
Huang X, Feng S, Chen W, Chen S, Chen Y, et al: The resistance of
esophageal cancer cells to paclitaxel can be reduced by the
knockdown of long noncoding RNA DDX11-AS1 through TAF1/TOP2A
inhibition. Am J Cancer Res. 9:2233–2248. 2019.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu H, Xu Y, Zhang D and Liu G: Long
noncoding RNA LUCAT1 promotes malignancy of ovarian cancer through
regulation of miR-612/HOXA13 pathway. Biochem Biophys Res Commun.
503:2095–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rojo AI, Medina-Campos ON, Rada P,
Zúñiga-Toala A, López-Gazcón A, Espada S, Pedraza-Chaverri J and
Cuadrado A: Signaling pathways activated by the phytochemical
nordihydroguaiaretic acid contribute to a Keap1-independent
regulation of Nrf2 stability: Role of glycogen synthase kinase-3.
Free Radic Biol Med. 52:473–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Golabchi K, Soleimani-Jelodar R, Aghadoost
N, Momeni F, Moridikia A, Nahand JS, Masoudifar A, Razmjoo H and
Mirzaei H: MicroRNAs in retinoblastoma: Potential diagnostic and
therapeutic biomarkers. J Cell Physiol. 233:3016–3023. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lulla RR, Costa FF, Bischof JM, Chou PM,
de F Bonaldo M, Vanin EF and Soares MB: Identification of
differentially expressed microRNAs in osteosarcoma. Sarcoma.
2011:7326902011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang C, Wu K, Wang S and Wei G: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
YAP via miR-195-5p. J Cell Biochem. 119:5646–5656. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, Wang Y, Sun L, Min J, Liu J, Chen
D, Zhang H, Zhang H, Zhang H, Zhou Y and Liu L: Long noncoding RNA
BC005927 upregulates EPHB4 and promotes gastric cancer metastasis
under hypoxia. Cancer Sci. 109:988–1000. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang Y, Ma Y, Li L, Shen X, Xin T, Zhao Y
and Ma R: Effect of long non-coding RNA LINC01116 on biological
behaviors of non-small cell lung cancer cells via the hippo
signaling pathway. J Cell Biochem. 119:63102018. View Article : Google Scholar
|
|
29
|
Zhang Y, Tao Y, Li Y, Zhao J, Zhang L,
Zhang X, Dong C, Xie Y, Dai X, Zhang X and Liao Q: The regulatory
network analysis of long noncoding RNAs in human colorectal cancer.
Funct Integr Genomics. 18:261–275. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
An N and Cheng D: The Long Noncoding RNA
HOST2 promotes gemcitabine resistance in human pancreatic cancer
cells. Pathol Oncol Res. 26:425–431. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H,
Kong J, Ding K, Shen HM, Wu H, et al: Long non-coding RNA
lincDUXAP8 regulated non-small cell lung cancer proliferation,
migration, invasion and epithelial mesenchymal transition by
sponging miR-150-5p. Mol Cancer. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin MG, Hong YK, Zhang Y, Lin BB and He
XJ: Mechanism of lncRNA DUXAP8 in promoting proliferation of
bladder cancer cells by regulating PTEN. Eur Rev Med Pharmacol Sci.
22:3370–3377. 2018.PubMed/NCBI
|
|
33
|
Huang T, Wang X, Yang X, Ji J, Wang Q, Yue
X and Dong Z: Long non-coding RNA DUXAP8 enhances renal cell
carcinoma progression via downregulating miR-126. Med Sci Monit.
14:7340–7347. 2018. View Article : Google Scholar
|
|
34
|
Wang R, Sun Y, Yu W, Yan Y, Qiao M, Jiang
R, Guan W and Wang L: Downregulation of miRNA-214 in
cancer-associated fibroblasts contributes to migration and invasion
of gastric cancer cells through targeting FGF9 and inducing EMT. J
Exp Clin Cancer Res. 38:202019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Weber CE, Luo C, Hotz-Wagenblatt A,
Gardyan A, Kordass T, Holland-Letz T, Osen W and Eichmüller SB:
miR-339-3p is a tumor suppressor in melanoma. Cancer Res.
76:3562–3571. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wong N, Yeo W, Wong WL, Wong NL, Chan KY,
Mo FK, Koh J, Chan SL, Chan AT, Lai PB, et al: TOP2A overexpression
in hepatocellular carcinoma correlates with early age onset,
shorter patients' survival and chemoresistance. Int J Cancer.
124:644–652. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Panvichian R, Tantiwetrueangdet A,
Angkathunyakul N and Leelaudomlipi S: TOP2A amplification and
overexpression in hepatocellular carcinoma tissues. Biomed Res Int.
2015:3816022015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chekerov R, Klaman I, Zafrakas M, Könsgen
D, Mustea A, Petschke B, Lichtenegger W, Sehouli J and Dahl E:
Altered expression pattern of topoisomerase IIalpha in ovarian
tumor epithelial and stromal cells after platinum-based
chemotherapy. Neoplasia. 8:38–45. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen CC, Gau JP, You JY, Lee KD, Yu YB, Lu
CH, Lin JT, Lan C, Lo WH, Liu JM and Yang CF: Prognostic
significance of beta-catenin and topoisomerase IIalpha in de novo
acute myeloid leukemia. Am J Hematol. 84:87–92. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen CF, He X, Arslan AD, Mo YY, Reinhold
WC, Pommier Y and Beck WT: Novel regulation of nuclear factor-YB by
miR-485-3p affects the expression of DNA topoisomerase IIα and drug
responsiveness. Mol Pharmacol. 79:735–741. 2011. View Article : Google Scholar : PubMed/NCBI
|
